The other one is SS 31 and SS 31 has actually been changed because some scandalous pharmaceutical company patented it for some diagnosis
CLINICAL PHARMACOLOGY : Mechanism of Action : Liraglutide is an acylated human Glucagon-Like Peptide-1 (GLP-1) receptor agonist with 97% amino acid sequence homology to endogenous human GLP-1(7-37)
This guide breaks down the safest peptides for muscle growth, their safety profiles and side effect rates, optimal dosing for safety and effectiveness, how to avoid common risks, which peptides to avoid as a beginner, and complete protocols that maximize muscle gains while minimizing health risks
The peptide also demonstrated an ability to increase fat oxidation and energy expenditure through pathways independent of beta-3 receptors
Use a food and symptom journal to identify patterns
It is not known if Saxenda will cause thyr oid tumors or a type of thyr oid cancer called medullary thyr oid carcinoma (MTC) in people